Replies to post #32371 on Intellipharmaceutics International Inc. (IPCI)

[doogdilinger]

In addition, the Company continues efforts to identify opportunities overseas, including in China, that could if effectuated provide product distribution alternatives through partnerships and therefore do not require an investment or asset acquisition by the Company.  The Company recently visited China where discussions toward establishing a partnership to facilitate future development activities are ongoing.  The Company has not entered into any such arrangements at this time.  These opportunities could involve out-licensing of our products, third-party manufacturing supply and more efficient access to pharmaceutical ingredients and therefore assist with the development of our growing product pipeline.

Not quite the detail/clarity we were hoping for on the recent China maneuvering...but I do think it's a clear indication that more news on exactly what that photo-op and contract signing between Smart Pharma(manufacturers) and Shanghai Pharma(distributors) actually entails may soon be forthcoming...at least that's what logic strongly suggests glta

[doogdilinger]

Wow impressive update on their Regabatin(Lyrica) NDA as it sure looks like it may finally be partnered and the NDA submitted to the FDA sometime in the back half of this year, at least judging by their statement made pertaining to the status of where Regabatin is at>>>

The Company believes its product has significant additional benefits to anything currently on the market and is very excited to continue development of its formulation.  We are currently evaluating partners for required Phase III studies and expect to begin these studies in the second half of 2018.

[doogdilinger]

Their proprietary PODRAS over-dose delivery technology could finally start creating some buzz soon woot-woot>>>

The human studies for PODRAS™ are expected to take place in the first half of 2018.  Based on the results of these studies, the Company will evaluate commercial opportunities for the technology including potential out-licensing as well as incorporation into products within our pipeline

.

[doogdilinger]

We have received considerable interest and are investigating several opportunities to develop products in collaboration with international partners.

Over +3 months now since mgmt. mentioned the above in their January operational update.

At this point progress on any area of their stagnant pipeline is sorely needed and should have a dramatic effect on their badly eroded share price!